Evidence map›Paper›PMID 42615637›Full record

ArticleACS chemical neuroscience2026

Human iPSC-Derived Spinal Cord Organoids - The First Electrophysiological Assessment of Neuronal Maturation.

Oleksandr Ievglevskyi, Denis Zosen, Jordi Requena Osete, Joel C Glover, Ragnhild Elizabeth Paulsen, Srdjan Djurovic, Elena Kondratskaya

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oleksandr IevglevskyiDepartment of Medical Genetics, Oslo University Hospital, Oslo0450, Norway.
Denis ZosenSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo0371, Norway.
Jordi Requena OseteDepartment of Medical Genetics, Oslo University Hospital, Oslo0450, Norway.
Joel C GloverLaboratory of Neural Development and Optical Recording (NDEVOR), Division of Physiology, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo0372, Norway.
Ragnhild Elizabeth PaulsenSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo0371, Norway.
Srdjan DjurovicDepartment of Medical Genetics, Oslo University Hospital, Oslo0450, Norway.ORCID 0000-0002-8140-8061
Elena KondratskayaDepartment of Medical Genetics, Oslo University Hospital, Oslo0450, Norway.ORCID 0000-0001-5066-5068

Funding

Livsvitenskap, Universitetet i Oslo NAS.G. S?nneland Foundation NA
6 · The paper itself

Abstract

The spinal cord exhibits a complex cytoarchitecture and neuronal circuitry organization that challenges in vitro replication of its functional integrity. Here we employed a previously published protocol to generate spinal cord organoids (SCOs) from human-induced pluripotent stem cells (hiPSCs). We characterized phenotypic changes in functional neuronal properties in SCO neurons at early developmental stages (15-32 days in culture) using a quantitative electrophysiological approach. Using the whole-cell patch-clamp technique to evaluate electrophysiological properties, we found that SCO neurons exhibited progressive maturation, as evidenced by hyperpolarized resting membrane potentials, increased inward current amplitude, refined action potential kinetics, and the early emergence of mature-type firing patterns. In particular, we show that the spike frequency adaptation phenomenon, which prevails in motor neurons, appears at early stages of SCO neuron development. Immunohistochemical assessment confirmed the expression of key transcription factors in motor neurons (ISLET1 and HB9) and immature spinal interneurons (LHX1/5 and PAX2). Collectively, our findings demonstrate that neurons in hiPSC-derived SCOs exhibit physiological differentiation, which is important for using SCOs to investigate human spinal cord development and advance translational research in CNS disorders and cell replacement therapies.

Indexed as

Induced Pluripotent Stem CellsNeuronsOrganoidsSpinal CordAction PotentialsCell DifferentiationHumansMembrane PotentialsMotor NeuronsNeurodevelopmentPatch-Clamp TechniquesTranscription FactorsTranscription Factorsdevelopmentelectrophysiological recordinghuman pluripotent stem cellsneuronal maturationspinal cord organoidswhole-cell patch clamp

Identifiers

PMID42615637
PMCPMC13495673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.